PRINT THIS PAGE US BioVista teams up with Swiss HBM Partners to launch $200m life sciences fund20/05/2004. Source: AltAssets. 
 US BioVista, a venture firm backed by not-for-profit Golden LEAF Foundation, has changed its name to Hatteras BioCapital and has teamed up with Swiss HBM Partners to launch a $200m life sciences fund.
The two firms joined forces after BioVista failed to secure adequate capital through its own fundraising efforts. The firm was initially targeting $120m for its stand-alone fund.
Golden LEAF, an organisation focussed on creating jobs in North Carolina, has provided a cornerstone investment of $30m. A number of other institutional investors, from the US and internationally, have brought total commitments so far to $95m, according to a report by newsobserver.com.
The fund will invest principally in later-stage biotechnology, pharmaceutical and medical device companies in North Carolina, but will also invest in other areas of the US and Europe.
Copyright © 2004 AltAssets
|
